{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T18:40:01Z","timestamp":1792780801476,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010763","name":"Zorginstituut Nederland","doi-asserted-by":"publisher","award":["Zorginstituut Nederland"],"award-info":[{"award-number":["Zorginstituut Nederland"]}],"id":[{"id":"10.13039\/501100010763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Socioeconomic health inequalities remain a persistent public health concern, and there is growing recognition of the potential role of health technology assessment (HTA) in addressing them. In the Netherlands, the National Health Care Institute (ZIN) does not formally consider socioeconomic status (SES) in the assessment stage of HTA. This study examined whether SES is considered in the appraisal stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed all publicly accessible meeting minutes of the appraisal committee published between 2013 and 2024. Minutes were screened for SES-related search terms, and contextual information was extracted on how SES was discussed. For minutes with more extensive SES-related discussions, it was examined whether SES considerations were reflected in final recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SES-related terms were identified in 18 of the 86 meeting minutes. Most references were brief and not followed by further discussion. More extensive discussion occurred in the context of four topics that were discussed in several meetings. Three of these topics concerned reimbursement decisions involving potential additional patient costs. The fourth concerned the updated assessment framework \u2018Necessity of insurance\u2019, in which health inequalities were included as a consideration. Across these four topics, SES was discussed in relation to financial vulnerability, affordability, and access to care for groups with limited resources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SES does not appear to be systematically considered in the appraisal stage of the HTA process at ZIN. Further research on deliberation and decision making is needed to assess whether and how SES should be incorporated into the decision-making framework and to explore methods allowing integrating SES-related considerations in both assessment and appraisal stages.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10198-026-01991-8","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:15:00Z","timestamp":1792732500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Examining the role of patients\u2019 socioeconomic status in the appraisal stage of health technology assessment in the Netherlands"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5338-6463","authenticated-orcid":false,"given":"Reva","family":"Efe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Reckers-Droog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Knies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"1991_CR1","doi-asserted-by":"crossref","unstructured":"Av\u015far, T. S., Yang, X., and P. Lorgelly. 2024. Equity in national healthcare economic evaluation guidelines: Essential or extraneous? Social Science & Medicine 357:117220.","DOI":"10.1016\/j.socscimed.2024.117220"},{"key":"1991_CR2","unstructured":"Broeders, D. W. J., H. D. Das, R. P. W. Jennissen, and W. L. Tiemeijer. & M. de Visser. 2018. Van Verschil Naar Potentieel: Een Realistisch Perspectief Op De Sociaaleconomische Gezondheidsverschillen [From Disparity to Potential: A Realistic Perspective on Socio-economic Health Inequalities]. WRR Policy Brief 7. The Hague: Scientific Council for Government Policy (WRR)."},{"key":"1991_CR3","unstructured":"Busschbach, J. 2010. Het pakketprincipe kosteneffectiviteit - achtergrondstudie ten behoeve van de \u2018appraisal\u2019 fase in pakketbeheer - CVZ."},{"key":"1991_CR4","unstructured":"Centraal Bureau voor de Statistiek (CBS). 2022. Bovenaan de welvaartsladder bijna 25 jaar langer in goede gezondheid. Available from: https:\/\/www.cbs.nl\/nl-nl\/nieuws\/2022\/51\/bovenaan-welvaartsladder-bijna-25-jaar-langer-in-goede-gezondheid#:~:text=Bovenaan%20welvaartsladder%20bijna%2025%20jaar%20langer%20in%20goede%20gezondheid,-21%2D12%2D2022&text=In%202021%20was%20de%20levensverwachting,en%20vrouwen%20ruim%2065%20jaar"},{"issue":"4","key":"1991_CR5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1017\/S1744133120000237","volume":"16","author":"JJ Enzing","year":"2021","unstructured":"Enzing, J. J. et al. 2021. Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride? Health Economics Policy and Law 16(4):440\u2013456.","journal-title":"Health Economics Policy and Law"},{"key":"1991_CR6","unstructured":"Equalis, Strategy. & Modeling en Pharos. 2022. Sociaaleconomische gezondheidsverschillen in relatie tot producten en adviezen van het Zorginstituut."},{"key":"1991_CR7","doi-asserted-by":"publisher","first-page":"111711","DOI":"10.1016\/j.jclinepi.2025.111711","volume":"181","author":"D Katsimpokis","year":"2025","unstructured":"Katsimpokis, D. et al. 2025. Income inequality and access to advanced immunotherapy for lung cancer: the case of Durvalumab in the Netherlands. Journal Of Clinical Epidemiology 181:111711.","journal-title":"Journal Of Clinical Epidemiology"},{"issue":"2","key":"1991_CR8","first-page":"1","volume":"18","author":"M Kroneman","year":"2016","unstructured":"Kroneman, M. et al. 2016. Netherlands: Health System Review. Health Syst Transit 18(2):1\u2013240.","journal-title":"Health Syst Transit"},{"issue":"8","key":"1991_CR9","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1093\/annonc\/mdx204","volume":"28","author":"A Kuijer","year":"2017","unstructured":"Kuijer, A. et al. 2017. The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands. Annals Of Oncology 28(8):1970\u20131978.","journal-title":"Annals Of Oncology"},{"issue":"23","key":"1991_CR10","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1056\/NEJMsa0707519","volume":"358","author":"JP Mackenbach","year":"2008","unstructured":"Mackenbach, J. P. et al. 2008. Socioeconomic inequalities in health in 22 European countries. New England Journal Of Medicine 358(23):2468\u20132481.","journal-title":"New England Journal Of Medicine"},{"issue":"9464","key":"1991_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(05)71146-6","volume":"365","author":"M Marmot","year":"2005","unstructured":"Marmot, M. 2005. Social determinants of health inequalities. Lancet 365(9464):1099\u20131104.","journal-title":"Lancet"},{"key":"1991_CR12","unstructured":"Ministerie van Financien. Belastingdienst - Kan ik zorgtoeslag krijgen? n.d. Available from: https:\/\/www.belastingdienst.nl\/wps\/wcm\/connect\/nl\/zorgtoeslag\/content\/kan-ik-zorgtoeslag-krijgen#:~:text=Een%20zorgverzekering%20is%20niet%20goedkoop,u%20niet%20te%20veel%20verdienen"},{"key":"1991_CR13","unstructured":"Ministerie van Financien. Dienst Toeslagen - Zorgtoeslag. n.d. Available from: https:\/\/www.overtoeslagen.nl\/onderwerpen\/z\/zorgtoeslag"},{"key":"1991_CR14","unstructured":"National Institute for Health and Care Excellence (NICE). 2025. Modular update to NICE Manuals - Health inequalities."},{"issue":"1","key":"1991_CR15","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1186\/s12889-022-13275-w","volume":"22","author":"WJ Nusselder","year":"2022","unstructured":"Nusselder, W. J. et al. 2022. Future trends of life expectancy by education in the Netherlands. Bmc Public Health 22(1):1664.","journal-title":"Bmc Public Health"},{"issue":"10476","key":"1991_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(24)02430-9","volume":"405","author":"J Pearson-Stuttard","year":"2025","unstructured":"Pearson-Stuttard, J., and B. Owolabi. 2025. Case for a health equity framework in health technology assessment. Lancet 405(10476):376\u2013377.","journal-title":"Lancet"},{"key":"1991_CR17","unstructured":"Raad van Volksgezondheid en Samenleving (RVS). 2020. Gezondheidsverschillen voorbij, Den Haag. Available from: https:\/\/www.raadrvs.nl\/documenten\/2020\/10\/03\/gezondheidsverschillen-voorbij."},{"issue":"6","key":"1991_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.healthpol.2018.04.001","volume":"122","author":"VT Reckers-Droog","year":"2018","unstructured":"Reckers-Droog, V. T., N. J. A. van Exel, and W. B. F. Brouwer. 2018. Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands. Health Policy 122(6):621\u2013629.","journal-title":"Health Policy"},{"issue":"8","key":"1991_CR19","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10198-024-01673-3","volume":"25","author":"V Reckers-Droog","year":"2024","unstructured":"Reckers-Droog, V., J. Enzing, and W. Brouwer. 2024. The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands. The European Journal Of Health Economics 25(8):1449\u20131459.","journal-title":"The European Journal Of Health Economics"},{"key":"1991_CR20","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Index SES-verschillen in (gezonde) levensverwachting. 2014. Available from: https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2014-0034.pdf"},{"key":"1991_CR21","unstructured":"Rijksoverheid. Kenniscentrum voor beleid en regelgeving - Doenvermogen. 2025. Available from: https:\/\/www.kcbr.nl\/ontwikkelen-beleid-en-regelgeving\/beleidskompas\/verplichte-kwaliteitseisen\/doenvermogen"},{"key":"1991_CR22","unstructured":"Rijksoverheid. Wat kost het om een zorgverzekering af te sluiten?. 2026. Available from: https:\/\/www.rijksoverheid.nl\/onderwerpen\/zorgverzekering\/vraag-en-antwoord\/premie-zorgverzekering"},{"issue":"3","key":"1991_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1377\/hlthaff.27.3.771","volume":"27","author":"WP Van de Ven","year":"2008","unstructured":"Van de Ven, W. P., and F. T. Schut. 2008. Universal mandatory health insurance in the Netherlands: a model for the United States? Health affairs 27(3):771\u2013781.","journal-title":"Health affairs"},{"issue":"6","key":"1991_CR24","doi-asserted-by":"publisher","first-page":"e101455","DOI":"10.1136\/gpsych-2023-101455","volume":"37","author":"M Zaneva","year":"2024","unstructured":"Zaneva, M. et al. 2024. What do we mean when we talk about socioeconomic status? Implications for measurement, mechanisms and interventions from a critical review on adolescent mental health. Gen Psychiatr 37(6):e101455.","journal-title":"Gen Psychiatr"},{"key":"1991_CR25","unstructured":"Zorginstituut Nederland. 2015. Kosteneffecitiveit in de praktijk."},{"key":"1991_CR26","unstructured":"Zorginstituut Nederland. Adviescommissie Pakket (ACP). n.d. Available from: https:\/\/www.zorginstituutnederland.nl\/over-ons\/commissies\/adviescommissie-pakket-acp"},{"key":"1991_CR27","unstructured":"Zorginstituut Nederland. Pakketbeheer. n.d. Available from: https:\/\/www.zorginstituutnederland.nl\/pakketbeheer"},{"key":"1991_CR28","unstructured":"Zorginstituut Nederland. Zvw-algemeen: hoe werkt de Zorgverzekeringswet? n.d. Available from: https:\/\/www.zorginstituutnederland.nl\/verzekerde-zorg\/z\/zvw-algemeen-hoe-werkt-de-zorgverzekeringswet"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-026-01991-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-026-01991-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-026-01991-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T18:02:36Z","timestamp":1792778556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-026-01991-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":28,"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1007\/s10198-026-01991-8","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ms. Efe reports being employed by the National Health Care Institute. Dr. Reckers-Droog reports no conflict of interest. Dr. Knies reports being employed by the National Health Care Institute. Dr. Brouwer reports being a member of the Scientific Advisory Board (WAR) of the National Health Care Institute. No other conflicts of interest are reported.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}